Ross Breckenridge, Director at REVA Medical, Inc. (RVA), bought 1,773 shares at $7.34 ($13K) on 2016-07-21, disclosed to the SEC on 2016-07-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.